Filtered By:
Source: Medscape Medical News Headlines
Management: Marketing

This page shows you your search results in order of date.

Order by Relevance | Date

Total 1 results found since Jan 2013.

EMA Recommends EU Marketing of Edoxaban in Atrial Fibrillation EMA Recommends EU Marketing of Edoxaban in Atrial Fibrillation
The recommendation is for prevention of stroke and systemic embolism in atrial fibrillation and for the treatment and prevention of DVT and PE.International Approvals
Source: Medscape Medical News Headlines - February 24, 2017 Category: Consumer Health News Tags: Cardiology News Source Type: news